Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jul 04 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jul-04-2023-3

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated July 04, 2023, titled "Zydus receives final approval from the USFDA for Oxcarbazepine Tablets USP, 150 mg, 300 mg and 600 mg".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases